No Data
No Data
Major Investment Alert: ProKidney Stock Sees Big Buy-In!
Here's Why We're Watching ProKidney's (NASDAQ:PROK) Cash Burn Situation
Down -38% in 4 Weeks, Here's Why You Should You Buy the Dip in PROKIDNEY CP (PROK)
ProKidney Hold Rating: Balancing Developmental Progress and Financial Stability Amid Uncertainty
ProKidney | 10-K: FY2024 Annual Report
ProKidney Corp. Reports 2024 Financial Results and Milestones in Rilparencel Development for Chronic Kidney Disease